IPG Health wins communications account around launch of new women’s health division of DR. KADE

Frankfurt am Main, February 03, 2021. IPG Health Germany wins the communications account around the new women’s health portfolio of pharmaceutical manufacturer DR. KADE Health Care. The Berlin-based family-owned company will expand its portfolio in 2021 to offer women comprehensive therapy concepts. DR. KADE is one of Germany’s leading providers in the field of women’s health and also sells products in the areas of proctology and gastroenterology, as well as vitamin preparations.

With immediate effect, IPG Health is working with DR. KADE on the communication around the launch of new products. The agency and the pharmaceutical manufacturer are working together on the concept, strategy, creation, production and packaging.

The new products will complement DR. KADE’s existing gynecological portfolio around the market leader KadeFungin as well as the KadeFemin medical intimate care range to provide women with a more holistic therapy offering.

IPG Health was able to convince in a pitch in mid-September 2020. The joint collaboration is already underway. The branding as well as the upcoming campaign will focus on the end consumer, physicians and pharmacies as the target group.

“We are very excited to partner with IPG Health and continue to pave the way for women’s independent health management in collaboration with gynecologists and pharmacists,” said Marie Krüger, Product Manager, DR. KADE.

“Accompanying the launch of DR. KADE’s expanded women’s health portfolio with communications is an exciting challenge for us. The issues affect millions of women and we want to draw attention to the new products that can help them,” says Joerg Hempelmann, CEO IPG Health.

The responsible pitch team IPG Health: Robert Schumacher, Inka Ficht (pitch lead), David Prater, Jamie MacCarthy Morrogh, Kai Baumann (creation); Colleen Arend, Fabio Mahle and Irini Papazoglou (strategy).

About DR. KADE Health Care

To improve the quality of life of people around the world and motivate them to take responsibility for their own health: That is the vision of the independent family-owned company DR. KADE – and has been doing so for 135 years. The pharmaceutical manufacturer has always focused on quality Made in Germany. Its key areas of expertise include gynecology, proctology, gastroenterology and vitamins. With its high-quality products and holistic therapy concepts, DR. KADE develops outstanding solutions for better health. This is ensured by an excellently trained team of over 300 employees at the Berlin site, where DR. KADE develops, produces and distributes pharmaceuticals and health products for Germany and the international market.

About IPG Health Germany

IPG Health Germany is part of the FCB Health Network, one of the world’s most award-winning communications networks focused on creating game-changing marketing solutions for consumers, patients and healthcare professionals.

With experts from around the world covering a wide range of health and wellness practices, FCB Health employs more than 2,500 people, more than 200 alone in Europe. The network offers multi-channel capabilities that include DTC and HCP communications, professional training and education, branding, scientific services, strategic planning and media services.

FCB Health Europe brings together teams from different countries, which are seamlessly connected and optimally assembled to meet the challenges faced by its clients. The network includes its own offices in Frankfurt am Main, Munich, Madrid, London and Hampshire and works with offices in Paris, Milan, Istanbul, Belgrade, Copenhagen, Amsterdam and Zurich. IPG Health Germany has offices in Frankfurt am Main and Munich. 

 

Contact

Jérôme Cholet

Public Relations and Communications Director

McCANN Worldgroup Germany

 

T › 49.(0)69.60507.142

F › 49.(0)69.60507.541

M › 49.(0)162.2942.764

[email protected]

[email protected]

 

www.mccannworldgroup.de